🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aurora Cannabis Inc. (TSX:ACB)
Canada flag Canada Β· Delayed Price Β· Currency is CAD
6.14
-0.17 (-2.69%)
Nov 19, 2026, 4:00 PM EST

Aurora Cannabis Earnings Call Transcripts

Fiscal Year 2027

Fiscal Year 2026

  • AGM 2026

    The AGM reviewed strong fiscal 2026 results, with double-digit revenue growth, improved margins, and a robust cash position. All management proposals passed, including director elections and auditor appointment. Strategic focus remains on global medical cannabis leadership and international expansion.

  • Net revenue and adjusted EBITDA exceeded guidance in FY26, driven by global medical cannabis growth and operational efficiencies. FY27 is expected to see lower revenue due to Canadian reimbursement changes, but international expansion and acquisitions like Safari Flower support long-term growth.

  • The company has completed a major restructuring, focusing on high-margin medical cannabis and divesting lower-margin segments. Strong growth is driven by international markets, especially Europe and Australia, supported by operational excellence, regulatory expertise, and a robust balance sheet.

  • Net revenue grew 7% year-over-year to CAD 94.2 million, led by strong global medical cannabis sales and international expansion. Adjusted gross margin reached 62%, with medical cannabis margins at 69%. Strategic exits from lower-margin segments and a new ATM equity program position the company for continued growth and profitability.

  • Net revenue grew 11% to $90.4M, led by record Global Medical Cannabis sales and strong international growth. Adjusted EBITDA rose 52% to $15.4M, with margins expanding and a robust cash position maintained. Regulatory changes in Canada and Europe present uncertainties.

  • Net revenue grew 17% to $98M, driven by 37% growth in medical cannabis and 85% international growth. Adjusted EBITDA more than doubled, margins improved, and free cash flow was positive. Outlook remains strong with continued revenue and margin expansion expected.

Fiscal Year 2025

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020